ZA796148B - Substituted5-(2-imidazolin-2-yl)-aminopyrimidines - Google Patents

Substituted5-(2-imidazolin-2-yl)-aminopyrimidines

Info

Publication number
ZA796148B
ZA796148B ZA00796148A ZA796148A ZA796148B ZA 796148 B ZA796148 B ZA 796148B ZA 00796148 A ZA00796148 A ZA 00796148A ZA 796148 A ZA796148 A ZA 796148A ZA 796148 B ZA796148 B ZA 796148B
Authority
ZA
South Africa
Prior art keywords
aminopyrimidines
imidazolin
Prior art date
Application number
ZA00796148A
Other languages
English (en)
Inventor
E Cohnen
W Stenzel
B Armah
W Fleck
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of ZA796148B publication Critical patent/ZA796148B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00796148A 1978-11-15 1979-11-15 Substituted5-(2-imidazolin-2-yl)-aminopyrimidines ZA796148B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (de) 1978-11-15 1978-11-15 Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ZA796148B true ZA796148B (en) 1980-11-26

Family

ID=6054732

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00796148A ZA796148B (en) 1978-11-15 1979-11-15 Substituted5-(2-imidazolin-2-yl)-aminopyrimidines

Country Status (4)

Country Link
JP (1) JPS5592383A (OSRAM)
BE (1) BE880042A (OSRAM)
DE (1) DE2849537C2 (OSRAM)
ZA (1) ZA796148B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016767A1 (de) * 1980-04-30 1981-11-05 Beiersdorf Ag, 2000 Hamburg Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung
DE3423293C2 (de) * 1984-06-23 1995-08-24 Lohmann Therapie Syst Lts Selbstklebendes Pflaster
DE3423328A1 (de) * 1984-06-23 1986-01-02 Beiersdorf Ag, 2000 Hamburg Selbstklebendes pflaster
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
PL372695A1 (en) 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
CA2637292A1 (en) * 2006-01-27 2007-08-16 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of cns disorders
EP1873151B1 (en) * 2006-06-26 2008-09-10 Chemagis Ltd. Improved process for producing moxonidine
CA2675221C (en) 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Novel 2-aminooxazolines as taar1 ligands
EP2121641B1 (en) 2007-02-15 2014-09-24 F. Hoffmann-La Roche AG 2-aminooxazolines as taar1 ligands
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
DE102012215896A1 (de) 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidinsynthese mit Hilfe organischer Basen
EP2738165B1 (en) 2012-12-03 2016-10-12 WÖRWAG PHARMA GmbH & Co. KG Method by means of phase transfer catalysis
EP2765131B1 (en) 2013-02-08 2016-11-23 Arevipharma GmbH Process for the production of Moxonidine
PT3430010T (pt) 2016-03-17 2020-09-10 Hoffmann La Roche Derivado de 5-etiol-4-metil-pirazol-3-carboxamida com atividade de agonista de taar
EP4243826A1 (en) * 2020-11-12 2023-09-20 3Z Ehf Novel treatments of attention deficit/hyperactivity disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
BE503170A (OSRAM) * 1975-09-02

Also Published As

Publication number Publication date
BE880042A (fr) 1980-05-14
JPS5592383A (en) 1980-07-12
DE2849537C2 (de) 1983-03-17
JPS6354714B2 (OSRAM) 1988-10-28
DE2849537A1 (de) 1980-05-22

Similar Documents

Publication Publication Date Title
GB2018765A (en) Iminoquinazolines
JPS54144633A (en) Cappholder
BG27580A1 (en) Two- poled pelvis- thight articulation- set
GB2024922B (en) Electroniclocks
JPS54104200A (en) Lifeeraft
JPS54145696A (en) Azolopyrimidinones
ZA796148B (en) Substituted5-(2-imidazolin-2-yl)-aminopyrimidines
GB2038315B (en) Spiro-polycyclic-imidazolidinediones
GB2013938B (en) Servocontrollers
CS333379A2 (en) Upinaci zarizeni
JPS554499A (en) Extension
JPS54160352A (en) Multiinuclear hindadophenol
CS846479A2 (en) Tkaci stroj
GB2029189B (en) Haymaker
JPS54122495A (en) Veneerrlace
GB2024809B (en) Mercaptopropionylglycine
GB2035954B (en) Derrik
GB2013592B (en) Play-vehicle
GB2014996A (en) Arylacetamidocephalosporins
JPS54149917A (en) Atmizer
JPS54128866A (en) Hydrooclclone
GB2021431B (en) Fuelinstallation
GB2023592B (en) Phenoxylalkanamides
JPS54163178A (en) Waterrspout
GB2018767A (en) Benzo-cyclitolamines